Alessandrea C. Quane - 15 Feb 2022 Form 4 Insider Report for Oscar Health, Inc. (OSCR)

Role
EVP, Chief Insurance Officer
Signature
/s/Allein Sabel, Attorney-in-Fact
Issuer symbol
OSCR
Transactions as of
15 Feb 2022
Net transactions value
-$354,280
Form type
4
Filing time
17 Feb 2022, 17:58:43 UTC
Previous filing
02 Sep 2021
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OSCR Class A Common Stock Options Exercise +125,000 125,000 15 Feb 2022 Direct F1
transaction OSCR Class A Common Stock Options Exercise +7,015 +5.6% 132,015 15 Feb 2022 Direct F1
transaction OSCR Class A Common Stock Sale $354,280 -49,355 -37% $7.18 82,660 16 Feb 2022 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OSCR Restricted Stock Units Options Exercise $0 -125,000 -25% $0.000000 375,000 15 Feb 2022 Class A Common Stock 125,000 Direct F1, F4
transaction OSCR Restricted Stock Units Options Exercise $0 -7,015 -6.2% $0.000000 105,236 15 Feb 2022 Class A Common Stock 7,015 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The sale was effected to satisfy the Reporting Person's tax withholding obligation upon the settlement of previously granted equity awards.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.12 to $7.2250, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F4 The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and vest with respect to the remaining shares in 12 equal quarterly installments thereafter.
F5 The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021.

Remarks:

Ex. 24 - Power of Attorney